Predicting PARP inhibitor sensitivity and resistance
نویسندگان
چکیده
A healthy diet rich in fruits and vegetables is an important part of a healthy lifestyle. Whereas epidemiological data sometimes fail to provide proof of this concept, molecular evidence is accumulating that clearly shows both preventive as well as therapeutic effects of compounds from natural origins. in the paper of Guido Kroemer's group about pro-autophagic polyphenols and their inhibitory effect on acetylation of cytoplasmic proteins, much emphasis is given to the relevance of this molecular mechanism in various diseases, including cardiovascular (French paradox) and neurodegenerative diseases as well as cancer. in fact, more than 75% of all anticancer drugs used in the clinics are of natural origins or at least inspired from nature. Based on this observation, many international research groups aim at discovering molecular mechanisms triggered or inhibited by compounds from nature. These compounds are sometimes controversially considered an excellent source for future preventive interventions as well as natural anticancer drugs able to target the main hallmarks of cancer or their enabling characteristics. Accordingly, molecular hallmarks that are efficiently inhibited by various natural compounds from the daily diet could be documented over the last decade. in our recent review, 1 various compounds from the " garden " are matched with their target signaling pathways: diallylpolysulfides from garlic induce cell cycle arrest and lead to apoptotic cell death; epigallocatechin 3-gallate (eGCG), curcumin and capsaicin were reported to inhibit epider-mal growth factor receptor (eGFR) cell signal-ing pathways; β-lapachone from the bark of Tabebuia avellanedae induces a reduction of the telomerase RNA level; flavonoids like lute-olin or genistein inhibit mechanisms linked to metastasis formation; angiogenesis is inhibited by plumbagin; methyl jasmonate inhibits cancer cell metabolism by active induction of hexokinase release; cordycepin inhibits PARP-1-involved base excision repair and finally a wealth of compounds were shown to inhibit pro-inflammatory cell signaling mechanisms including NFκB and Jak/STAT. it becomes clear that even from our diet, nature provides arrays of molecules able to interfere with all crucial steps of carcinogenesis, covering initiation, promotion and progression of the disease. Natural compounds that interfere with autophagic mechanisms are much less investigated and, accordingly, deserve particular attention, as they could lead to therapeutic applications in cancer types resistant toward apoptotic cell death. in the report by Pietrocola et al., 3 authors show that pro-autophagic polyphenols reduce the acetylation level of cytoplasmic proteins, and that a cause-effect relationship between this deacetylation and autophagy induction by red wine components exists. …
منابع مشابه
Phosphorylation of ribosomal protein S6 confers PARP inhibitor resistance in BRCA1-deficient cancers
Inhibition of poly(ADP-ribose) polymerase (PARP) is a promising therapeutic strategy for BRCA1 deficient cancers, however, the development of drug resistance limits clinical efficacy. Previously we found that the BRCA1-AKT1 pathway contributes to tumorigenesis and that the AKT1/mTOR is a novel therapeutic target for BRCA1-deficient cancers. Here, we report that phosphorylation of ribosomal prot...
متن کاملNF-κB signaling mediates acquired resistance after PARP inhibition
PARP inhibitors are a class of promising anti-cancer drugs, with proven activity in BRCA mutant cancers. However, as with other targeted agents, treatment with PARP inhibitors generates acquired resistance within these tumors. The mechanism of this acquired resistance is poorly understood. We established cell lines that are resistant to PARP inhibitor by continuous treatment with the drug, and ...
متن کاملEffects of poly (ADP-ribosyl) polymerase (PARP) inhibitor on cisplatin resistance & proliferation of the ovarian cancer C13* cells
BACKGROUND & OBJECTIVES Drug resistance is the primary cause of failure in the treatment of cancers. It has been suggested that the enhancement of DNA repair capability may be responsible for the drug resistance of the tumour cells, and poly(ADP-ribosyl)ation plays an important role in DNA repair. This study investigated the effect of PARP inhibitor 3-aminobenzamide (3-AB) on the cisplatin resi...
متن کاملNovel Poly(Adenosine Diphosphate-Ribose) Polymerase (PARP) Inhibitor, AZD2461, Down-Regulates VEGF and Induces Apoptosis in Prostate Cancer Cells
Background: Prostate cancer (Pca) is a heterogeneous disease, and current treatments are not based on molecular stratification. Poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibitors have recently been found to be remarkably toxic to cells with defects in homologous recombination, particularly cells with BRCA-mutated backgrounds. Therefore, this preliminary study was designed to ...
متن کاملINVITED COMMENTARY Biomarkers of PARP inhibitor sensitivity
The PARP inhibitors represent one of the most exciting recent developments in cancer therapy. Substantial efficacy has been shown with PARP inhibitors in the treatment of hereditary BRCA1/2 related Breast and Ovarian cancer as single agents [1–3] and in combination with temozolomide [4]. Similarly, encouraging activity has been shown in sporadic ovarian cancer with a PARP inhibitor as a single ...
متن کاملPredictors and Modulators of Synthetic Lethality: An Update on PARP Inhibitors and Personalized Medicine
Poly(ADP-ribose) polymerase (PARP) inhibitors have proven to be successful agents in inducing synthetic lethality in several malignancies. Several PARP inhibitors have reached clinical trial testing for treatment in different cancers, and, recently, Olaparib (AZD2281) has gained both United States Food and Drug Administration (USFDA) and the European Commission (EC) approval for use in BRCA-mut...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 11 شماره
صفحات -
تاریخ انتشار 2012